Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Serine Augmentation of Cognitive Retraining in Schizophrenia
NCT00237848Phase 3Completed
- Sponsor
- Yale University
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of d-serine in schizophrenia and schizoaffective disorder, sponsored by Yale University. Started Feb 2005; status: completed.
02
Drugs
d-serine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00237848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237848.